Decreased cutaneous vasodilatation to isometric handgrip exercise in Alzheimer's disease by Kálmán, János et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
Int J Geriatr Psychiatry 2002; 17: 371–374.
Published online in Wiley InterScience (www.interscience.wiley.com). DOI: 10.1002/gps.609
Decreased cutaneous vasodilatation to isometric handgrip
exercise in Alzheimer’s disease
Ja´nos Ka´lma´n1*, Re´ka Szaka´cs1, Tama´s To¨ro¨k2, Zsuzsa Ro´zsa3y, Pa´l Barzo´4,
La´szlo´ Rudas2, J. Gy. Papp3 and Zolta´n Janka1
1Department of Psychiatry, University of Szeged, Hungary
2Medical Intensive Care Unit, University of Szeged, Hungary
3Department of Pharmacology, University of Szeged, Hungary
4Department of Neurosurgery, University of Szeged, Hungary
SUMMARY
Background Cutaneous active vasodilatation is a cholinergic nerve mediated function of the sympathetic nervous system
and the disturbed function of cholinergic neurotransmission is known as a prominent feature of Alzheimer’s disease (AD).
Methods To assess this relationship, skin blood flow (SkBF) and other haemodynamic parameters were determined by a sim-
ple vasodilatory test, isometric handgrip exercise (IHG), in 22 late-onset sporadic type AD and 20 aged control persons (AC).
Results Significantly higher cutaneous vascular resistance and decreased SkBF were found after the stimulus in the AD
group. A smaller reduction ( p< 0.03) of R wave intervals on the electrocardiogram was observed in the AD group compared
to the AC one. After IHG, change in systolic blood pressure was less in the AD ( p< 0.01) than in the AC group.
Conclusion Our results suggest that autonomic dysfunction affecting active vasodilator sympathetic, as well as parasym-
pathetic functions is present in AD. Copyright # 2002 John Wiley & Sons, Ltd.
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INTRODUCTION
Several lines of evidence indicate that the autonomic
nervous system is affected in Alzheimer’s disease
(AD). Hypotension and disturbed circadian rhythm
of blood pressure (BP) were found to be associated
with this type of dementia (Otsuka et al., 1990; Burke
et al., 1994; Guo et al., 1996). Thermoregulatory
dysfunction has also been reported in AD (Printz
et al., 1984; Diamond and Diamond, 1991). In addi-
tion, AD patients displayed an impairment in noradre-
nergic response to orthostasis (Jhee et al., 1995) and
attenuated skin vascular response to cholinergic sub-
stances iontophoresed into the skin has been observed
(Algotsson et al., 1995). These vasoregulatory distur-
bances are consistent with the finding, that the central
neurons regulating BP degenerate in AD (Burke et al.,
1994). Autonomic, cholinergic and other brainstem
nuclei (e.g. parabrachial nucleus involved in homeo-
static control and integration of visceral information)
were also found to be affected in AD (Parvizi et al.,
2001). These findings could also support the auto-
nomic dysfunctions in patients with AD, including
parasympathetic as well as sympathetic cardiovascu-
lar alterations. Cutaneous active vasodilatation is a
cholinergic nerve mediated function of the sympa-
thetic nervous system. However, there has been no
information available on the active skin vasoregula-
tory function of AD patients. A simple method, the
isometric handgrip exercise (IHG) (Taylor et al.,
1989) was used in the present study to examine this
function.
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SUBJECTS AND METHODS
Subjects
Twenty-two patients with a diagnosis of probable AD
and 20 healthy aged control (AC) subjects with simi-
lar age and sex distributions participated in the study.
All AD probands were selected from the in- and out-
patient units of the local memory clinic. The AC sub-
jects were recruited from elderly persons belonging to
the hospital staff and from healthy elderly people
from the community. The clinical diagnosis of AD
was based on the Diagnostic and Statistical Manual
of Mental Disorders (DSM-IV; APA, 1994) and
NINCDS-ADRDA (McKhann et al., 1984) criteria.
Work-ups included the subjects’ physical, psychiatric
and family history, neurological and psychiatric
examination, routine laboratory tests (including thyr-
oid function tests), neuroimaging (cerebral computer-
ized tomography (CT) or magnetic resonance
imaging (MRI), electrocardiography, electroencepha-
lography and psychometric evaluations: the Mini-
Mental State Exam (MMSE; Folstein et al., 1975)
and the Cued Recall Test (CRT; Grober and Buschke,
1987). The subjects’ characteristics are presented in
Table 1. All subjects were Caucasian, non-smokers
and they were not on medication which alter skin ves-
sel reactivity. Probands with a history or sign of psy-
chiatric disorder, malignancy, diabetes mellitus,
hypertension, skin, cerebro- and cardiovascular dis-
ease were excluded from further investigations. Other
selection criteria were not used to select or subgroup
the AD probands. Before each measurement with a
new proband, a ‘trial probe’ was included in order
to assess the proband’s capacity to cooperate. There
were severely demented AD subjects, who could not
cooperate during the experiment therefore they were
excluded from further participation. Informed consent
was obtained from all probands and, if appropiate,
from family members or caregivers. The study
protocol was approved by the local Human
Biomedical Research Ethics Committee.
Experimental procedure
All measurements were performed between 2:00 and
5:00 pm, in the same room at constant temperature.
All probands were left for 30 min in a supine resting
position to acclimatize them to the surroundings
before the start of the measurements. Mean arterial
blood pressure (MAP), systolic and diastolic blood
pressure (DBP and SBP), skin blood flow (SkBF)
and skin temperature were monitored continuously
in the same position, attached to the ventral side of
nonexercising forearm. Blood pressure recordings
were made on the 3rd finger of the nonexercising hand
placed at heart level. SkBF was measured by means of
a double-channel laser-Doppler perfusion monitor
(Perimed, Stockholm, Sweden) attached to the ventral
side of the non-dominant, non-exercising forearm. A
Finapres 2300 (Ohmeda) non-invasive blood pressure
monitor was used to measure BP continuously on the
same side. ECG was monitored with a Sirecust 730
(Siemens, Germany) monitor. The signals of ECG
(R wave) plethysmograph were amplified and filtered
to an analog signal by a digital converter. All data
were collected and stored in an IBM-AT compatible
computer. Maximal voluntary contraction (VC) was
determined by an exercise dynamometer. No differ-
ences were observed in the strength of the VC
between the groups. Thirty percent of maximal VC,
monitorized by exercise dynamometer, was used for
2 min to perform the isometric handgrip exercise
(IHG). The same procedure was repeated twice more
with 2 min resting periods between the measurements.
Data analysis
MAP was calculated as the sum of diastolic blood
pressure þ 1=3 of the pulse pressure. Skin blood flow
was expressed as percentage of maximal skin blood
flow. Cutaneous vascular resistance (CVR) was calcu-
lated as MAP/SkBF. The change in CVR (dCVR) was
calculated according to dCVR¼ (CVRmax
CVRbase)/CVRbase, where base values were mea-
sured before IHG and maximal (max) values during
the test. Differences between mean values were exam-
ined by Student t-test for continuous variables (age of
probands and haemodynamic parameters) and chi-
square test was used for non-parametric values (test
scores). All the parametric data had normal distribu-
tion. Statistics was calculated with SPSS program.
Significance levels were set at p< 0.05.
Table 1. Clinical characteristics and neurodiagnostic test scores of
probands
Control subjects Alzheimer patients
(n¼ 20) (n¼ 22)
Age (years) 72.0 6.3 72.9 6.5
Male/female 6=14 8=14
Age of onset (years) — 66.9 7.4
MMSE score 29.0 0.9 19.0 6.5*
CRT-I. score 25.3 2.5 11.4 6.3#
CRT-II. score 22.0 3.0 16.5 9.2
Data are meanSD; chi-square test: *p< 0.000; #p< 0.007;
MMSE¼Mini-Mental State Examination; CRT-I.¼Cued Recall
Test, free recall; CRT-II.¼Cued Recall Test, cued recall.
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RESULTS
A reduction of R wave intervals as a result of IHG was
observed in both groups (Table 2), but the decrease
was significantly smaller in the AD than in the AC
group. The static exercise increased changes in both
systolic blood pressure (dSBP) and diastolic blood
pressure (dDBP) in all groups, but the dSBP was sig-
nificantly smaller in AD patients than in the controls.
The increase of SkBF was significantly smaller in the
case of AD probands, and significantly higher dCVR
was calculated for the same group. The resting R wave
interval value from the ECG (RR) correlated signifi-
cantly with the severity of dementia (MMSE score)
(r¼ 0.662; p< 0.004). A highly significant negative
correlation (r¼0.711; p< 0.001) was calculated
for the resting SkBF with the age of all probands.
DISCUSSION
The human nonglabrous SkBF is known to be regu-
lated by the sympathetic vasoconstrictor and vasodi-
latator system. Active vasoconstrictor nerves secrete
norepinephrine acting on postsynaptic 1 and 2
receptors (Lindblad and Ekenvall, 1986). On the other
hand, cutaneous active vasodilatation has been proven
to be mediated by cholinergic nerve cotransmission
(Kellogg et al., 1995; Rowell, 1977).
The main observation of this study is that the AD
patients have impaired skin vasodilatory function,
and this impairment could be revealed with a simple
muscle exercise test. Our results support the find-
ings of Algotsson et al. (1995a), who observed a
significantly decreased skin vessel reactivity after
local, iontophoretical administration of cholinergic
agents. Interestingly, the AD patients possessing the
apolipoprotein E "4 allele (ApoE4) displayed
enhanced vascular reactivity to the iontophoretic acet-
ylcholine (Algotsson et al., 2000). Recent evidence
indicates that ApoE4 is linked to AD (Ka´lma´n et al.,
1997; Poirier, 1999), supporting the possibility that
dysfunctions of the lipid transport system and/or other
membrane abnormalities are associated with the AD
process. The present investigation has provided
further analysis of vascular responses in AD and
proved that impaired skin vessel vasodilatation
(decreased dSkBF and increased dCVR) is present
during such a physiological activity as IHG. These
results indicate that the autonomic part of the choli-
nergic system is affected in AD and that the functional
vascular abnormalities are not restricted to cerebral
microvasculature.
The change in CVR response to IHG is considered
as a result of various neural and humoral effects
(Crandall et al., 1995; Kellogg et al., 1995). This
vasodilatation is presumably mediated by cholinergic
sympathetic mechanism, although the response is
greatly influenced by other factors, such as coinciding
thermal stimulus (Crandall et al., 1995). Among the
AC, an exercise-induced increase in the cutaneous
blood flow was documented in this study. With the
simultaneous increase of BP, the changes in the calcu-
lated CVR were negligible. In contrast, the SkBF
response of AD patients was limited, with a definite
increase in calculated CVR. Systemic arterial pres-
sures were not different between the two groups, sug-
gesting that the changes in cutaneous blood flow
during IHG are due to local vasomotor abnormalities
in AD. We suppose that the response of the AD
patients reflects an opposed vasoconstrictor i.e. defec-
tive vasodilation mechanism. It is pertinent to men-
tion here that the acetylcholine induced vasodilation
is known to be mediated by endothelium-derived
relaxing factors, such as nitric oxide (NO) (Crandall
et al., 1995). Furthermore, it has been proven that
the process of aging progressively reduces both
endothelium-derived NO production in experimental
animals (Broten et al., 1992) and endothelium depen-
dent vasodilatation in forearm resistance vessels in
humans (Gerhard et al., 1995). Therefore the
impaired cutaneous vasodilatation of AD probands
could be the consequence of disturbed cholinergic
function and/or altered production of endothelium
derived NO. Our results do not permit the localization
of the disturbances however. The finding, that the AD
probands displayed altered sympathovagal tone
Table 2. Changes of various haemodynamic parameters to
isometric handgrip exercise
Control Alzheimer
subjects patients
(n¼ 20) (n¼ 22)
dRR (ms) 162 94.9 108 51.4 t¼ 2.32 p< 0.025
dMAP 37 16 31 12
(Hgmm)
dSBP 48 17 35 12 t¼ 2.79 p< 0.009
(Hgmm)
dDBP 29 12 25 12
(Hgmm)
SkBF (%) 25 33.1 5 25.2 t¼ 2.02 p< 0.05
dCVR 0.08 0.419 0.32 0.288 t¼ 2.18 p< 0.035
dRR, R wave interval changes from the electrocardiogram; dMAP,
mean blood pressure changes; dSBP, systolic blood pressure
changes; dDBP, diastolic blood pressure changes; dCVR, changes
in cutaneous vascular resistance; SkBF, skin blood flow (% of
maximal skin blood flow); Hgmm, millimeters of Mercury. Data are
meanSD. Students t-test was applied.
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(having decreased dRR intervals after the IHG test),
reflects that the central autonomic control of cardiac
function is also affected in AD. These results confirm
the findings of Elmstahl et al. (1992), Aharon-Peretz
et al. (1992) and Algotsson et al. (1995a, 1995b)
using a different experimental approach. Alterations
of RR intervals are considered as a marker of the
function of the parasympathetic nervous system
regulated by the dorsal vagal nucleus (Aharon-Peretz
et al., 1992).
In summary, the results of the present study provide
further evidence that the autonomic nervous system is
impaired in AD. The IHG test could be a useful moni-
tor to follow these alterations over time.
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